RECOMBINATE Side Effects

6922728-1 | Pneumocystis Jiroveci Pneumonia
on Aug 06, 2010 Male patient from UNITED STATES , 36 years of age, was diagnosed with haemorrhage and was treated with Recombinate (View Usage). Patient experienced the following unwanted or unexpected effects: pneumocystis jiroveci pneumonia. Recombinate dosage: . Patient was hospitalized.

6814220-X | Cyanosis, Pyrexia, Tremor
Patient was taking Recombinate (View Usage). Patient had the following side effects: cyanosis, pyrexia, tremor on Jun 21, 2010 from TURKEY Additional patient health information: Male patient , child 10 years of age, weighting 83.78 lb, was diagnosed with haemophilia, traumatic haemorrhage and. Recombinate dosage: . Patient was hospitalized.

6771495-3 |
Adverse event was reported on Jun 09, 2010 by a Male patient taking Recombinate (View Usage) (Dosage: ) . Location: UNITED STATES , 30 years of age, .

6767410-9 | Cyanosis, Pyrexia, Tremor
on Jun 03, 2010 Male patient from TURKEY , child 10 years of age, weighting 83.78 lb, was diagnosed with haemophilia, traumatic haemorrhage and was treated with Recombinate (View Usage). Patient experienced the following unwanted or unexpected effects: cyanosis, pyrexia, tremor. Recombinate dosage: . Patient was hospitalized.


6764115-5 | Infection
on May 31, 2010 Male patient from AUSTRALIA , child 4 years of age, was diagnosed with coagulation factor viii level abnormal and was treated with Recombinate (View Usage). Patient had the following side effects: infection (What is infection?). Recombinate dosage: .

6717106-4 | Cyanosis, Pyrexia, Tremor
Patient was taking Recombinate (View Usage). After Recombinate was administered, patient had the following side effects: cyanosis, pyrexia, tremor on May 03, 2010 from TURKEY Additional patient health information: Male patient , child 10 years of age, weighting 83.78 lb, was diagnosed with haemophilia, traumatic haemorrhage and. Recombinate dosage: . Patient was hospitalized.

6663741-1 | Cyanosis, Pyrexia, Tremor
Adverse event was reported on Mar 22, 2010 by a Male patient taking Recombinate (View Usage) (Dosage: ) was diagnosed with haemophilia, traumatic haemorrhage and. Location: TURKEY , child 10 years of age, weighting 83.78 lb, Patient experienced the following unwanted or unexpected effects: cyanosis, pyrexia, tremor. Patient was hospitalized.

6610375-0 | Cyanosis, Pyrexia, Tremor
on Feb 16, 2010 Male patient from TURKEY , child 10 years of age, weighting 83.78 lb, was diagnosed with haemophilia, traumatic haemorrhage and was treated with Recombinate (View Usage). Patient had the following side effects: cyanosis, pyrexia, tremor. Recombinate dosage: . Patient was hospitalized.

6599285-5 | Cyanosis, Pyrexia, Tremor
on Feb 16, 2010 Male patient from TURKEY , child 10 years of age, weighting 83.78 lb, was diagnosed with haemophilia, traumatic haemorrhage and was treated with Recombinate (View Usage). After Recombinate was administered, patient had the following side effects: cyanosis, pyrexia, tremor. Recombinate dosage: . Patient was hospitalized.

6589190-2 |
Patient was taking Recombinate (View Usage). on Feb 10, 2010 from UNITED STATES Additional patient health information: Male patient , 50 years of age, was diagnosed with haemophilia and. Recombinate dosage: .

6393124-3 |
Adverse event was reported on Sep 28, 2009 by a Male patient taking Recombinate (View Usage) (Dosage: ) was diagnosed with haemophilia and. Location: UNITED STATES , 51 years of age, .

6282223-2 | Haemorrhage
on Jul 10, 2009 Male patient from FINLAND , child 8 years of age, was diagnosed with factor viii deficiency and was treated with Recombinate (View Usage). After Recombinate was administered, patient had the following side effects: haemorrhage. Recombinate dosage: . Patient was hospitalized.

6273314-0 | Haemorrhage
on Jul 09, 2009 Male patient from FINLAND , child 8 years of age, was diagnosed with factor viii deficiency and was treated with Recombinate (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage. Recombinate dosage: . Patient was hospitalized.

6234652-0 | Haemorrhage
Patient was taking Recombinate (View Usage). Patient had the following side effects: haemorrhage on Jun 10, 2009 from FINLAND Additional patient health information: Male patient , child 8 years of age, was diagnosed with factor viii deficiency and. Recombinate dosage: . Patient was hospitalized.

6220489-5 | Haemorrhage
Adverse event was reported on Jun 03, 2009 by a Male patient taking Recombinate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: FINLAND , child 8 years of age, After Recombinate was administered, patient had the following side effects: haemorrhage. Patient was hospitalized.

6143038-9 |
on Mar 30, 2009 Male patient from AUSTRALIA , 55 years of age, was diagnosed with haemophilia and was treated with Recombinate (View Usage). . Recombinate dosage: .

6130075-3 |
on Mar 15, 2009 Male patient from AUSTRALIA , 55 years of age, was diagnosed with haemophilia and was treated with Recombinate (View Usage). . Recombinate dosage: .

6120386-X | Abdominal Pain, Cold Sweat, Epistaxis, Infusion Related Reaction, Infusion Site Extravasation, Infusion Site Pain, Nausea
Patient was taking Recombinate (View Usage). After Recombinate was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), cold sweat, epistaxis, infusion related reaction, infusion site extravasation, infusion site pain, nausea (What is nausea?) on Mar 16, 2009 from UNITED STATES Additional patient health information: Male patient , 14 years of age, weighting 162.5 lb, was diagnosed with haemophilia and. Recombinate dosage: 1569units Weekly Iv Bolus.

6099247-0 | Hepatitis C, Hiv Infection
Adverse event was reported on Feb 20, 2009 by a Male patient taking Recombinate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: FRANCE , 49 years of age, Patient experienced the following unwanted or unexpected effects: hepatitis c (What is hepatitis c?), hiv infection (What is hiv infection?). During the same period patient was treated with ANTIHEMOPHILIC FACTOR (HUMAN) (View Antihemophilic Factor (human) Review and Antihemophilic Factor (human) Label ).

6069163-9 | Abdominal Pain, Blood Culture Positive, Chest Pain, Dyspnoea
on Feb 02, 2009 Male patient from AUSTRALIA , child 6 years of age, was treated with Recombinate (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), blood culture positive, chest pain (What is chest pain?), dyspnoea. Recombinate dosage: .

6029093-5 | Abdominal Pain, Blood Culture Positive, Chest Pain, Dyspnoea
on Dec 29, 2008 Male patient from AUSTRALIA , child 6 years of age, was treated with Recombinate (View Usage). After Recombinate was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), blood culture positive, chest pain (What is chest pain?), dyspnoea. Recombinate dosage: .

5948831-0 | Accidental Overdose
Patient was taking Recombinate (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose on Nov 02, 2008 from UNITED STATES Additional patient health information: Male patient , 30 years of age, weighting 198.4 lb, was diagnosed with haemophilia and. Recombinate dosage: . During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), TYLENOL W/ CODEINE NO. 3 (View Tylenol W/ Codeine No. 3 Review and Tylenol W/ Codeine No. 3 Label ), XANAX (View Xanax Review and Xanax Label ), PERCOCET (View Percocet Review and Percocet Label ), AMBIEN (View Ambien Review and Ambien Label ).

5944866-2 | Haemorrhage
Adverse event was reported on Oct 28, 2008 by a Male patient taking Recombinate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: CHINA , 14 years of age, weighting 92.59 lb, Patient had the following side effects: haemorrhage. Patient was hospitalized.

5903469-6 | Haemorrhage
on Sep 19, 2008 Male patient from CHINA , 14 years of age, weighting 92.59 lb, was diagnosed with factor viii deficiency and was treated with Recombinate (View Usage). After Recombinate was administered, patient had the following side effects: haemorrhage. Recombinate dosage: . Patient was hospitalized.

5896045-5 | Embolism
on Sep 18, 2008 Male patient from UNITED STATES , child 4 years of age, was treated with Recombinate (View Usage). Patient experienced the following unwanted or unexpected effects: embolism. Recombinate dosage: . Patient was hospitalized.

5856961-7 | Accidental Overdose
Patient was taking Recombinate (View Usage). Patient had the following side effects: accidental overdose on Aug 14, 2008 from UNITED STATES Additional patient health information: Male patient , 30 years of age, was diagnosed with haemophilia and. Recombinate dosage: . During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ).

5788090-5 | Sarcoma
Adverse event was reported on Jun 17, 2008 by a Male patient taking Recombinate (View Usage) (Dosage: ) . Location: UNITED STATES , 76 years of age, After Recombinate was administered, patient had the following side effects: sarcoma.

5752771-X | Hepatitis B Dna Assay Positive, Hepatitis B Surface Antigen Positive
on May 20, 2008 Male patient from KOREA, REPUBLIC OF , weighting 61.73 lb, was diagnosed with haemarthrosis and was treated with Recombinate (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis b dna assay positive, hepatitis b surface antigen positive. Recombinate dosage: .

5746828-7 | Anti-hbs Antibody Positive, Hepatitis C Antibody Positive
on May 16, 2008 Male patient from JAPAN , 20 years of age, weighting 114.6 lb, was diagnosed with factor viii deficiency and was treated with Recombinate (View Usage). Patient had the following side effects: anti-hbs antibody positive, hepatitis c antibody positive. Recombinate dosage: . During the same period patient was treated with OCTOCOG ALFA (View Octocog Alfa Review and Octocog Alfa Label ).

5701384-4 | Hepatitis B Dna Assay Positive, Hepatitis B Surface Antigen Positive
Patient was taking Recombinate (View Usage). After Recombinate was administered, patient had the following side effects: hepatitis b dna assay positive, hepatitis b surface antigen positive on Apr 04, 2008 from KOREA, REPUBLIC OF Additional patient health information: Male patient , weighting 61.73 lb, was diagnosed with haemarthrosis and. Recombinate dosage: .

5694142-0 | Hepatitis B Dna Assay Positive, Hepatitis B Surface Antigen Positive
Adverse event was reported on Mar 24, 2008 by a Male patient taking Recombinate (View Usage) (Dosage: ) was diagnosed with haemarthrosis and. Location: KOREA, REPUBLIC OF , weighting 61.73 lb, Patient experienced the following unwanted or unexpected effects: hepatitis b dna assay positive, hepatitis b surface antigen positive.

5580638-9 | Aphasia, Hepatitis C, Subdural Haematoma
on Dec 24, 2007 Male patient from UNITED STATES , 43 years of age, weighting 174.2 lb, was diagnosed with factor viii deficiency, prophylaxis and was treated with Recombinate (View Usage). Patient had the following side effects: aphasia (What is aphasia?), hepatitis c (What is hepatitis c?), subdural haematoma. Recombinate dosage: . During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), REYATAZ (View Reyataz Review and Reyataz Label ), NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), COLERITE (View Colerite Review and Colerite Label ). Patient was hospitalized.

5492625-X | Factor Viii Inhibition
on Oct 12, 2007 Male patient from JAPAN , 30 years of age, weighting 152.1 lb, was diagnosed with factor viii deficiency and was treated with Recombinate (View Usage). After Recombinate was administered, patient had the following side effects: factor viii inhibition. Recombinate dosage: . Patient was hospitalized.

5466164-6 | Factor Viii Inhibition
Patient was taking Recombinate (View Usage). Patient experienced the following unwanted or unexpected effects: factor viii inhibition on Sep 12, 2007 from JAPAN Additional patient health information: Male patient , 30 years of age, weighting 152.1 lb, was diagnosed with factor viii deficiency and. Recombinate dosage: . Patient was hospitalized.

5452595-7 | Factor Viii Inhibition
Adverse event was reported on Sep 03, 2007 by a Male patient taking Recombinate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: JAPAN , 30 years of age, weighting 152.1 lb, Patient had the following side effects: factor viii inhibition. Patient was hospitalized.

5417342-3 | Factor Viii Inhibition
on Aug 13, 2007 Male patient from JAPAN , weighting 19.84 lb, was diagnosed with factor viii deficiency and was treated with Recombinate (View Usage). After Recombinate was administered, patient had the following side effects: factor viii inhibition. Recombinate dosage: . During the same period patient was treated with ADVATE (View Advate Review and Advate Label ). Patient was hospitalized.

5404505-6 | Factor Viii Inhibition
on Jul 23, 2007 Male patient from JAPAN , weighting 19.84 lb, was diagnosed with factor viii deficiency and was treated with Recombinate (View Usage). Patient experienced the following unwanted or unexpected effects: factor viii inhibition. Recombinate dosage: . During the same period patient was treated with ADVATE (View Advate Review and Advate Label ). Patient was hospitalized.

5377475-7 | Factor Viii Inhibition
Patient was taking Recombinate (View Usage). Patient had the following side effects: factor viii inhibition on Jun 26, 2007 from JAPAN Additional patient health information: Male patient , 32 years of age, weighting 152.1 lb, was diagnosed with factor viii deficiency and. Recombinate dosage: .

5377474-5 | Factor Viii Inhibition
Adverse event was reported on Jun 26, 2007 by a Male patient taking Recombinate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: JAPAN , 32 years of age, weighting 152.1 lb, After Recombinate was administered, patient had the following side effects: factor viii inhibition.

5358965-X | Factor Viii Inhibition
on Jun 06, 2007 Male patient from JAPAN , weighting 19.84 lb, was diagnosed with factor viii deficiency and was treated with Recombinate (View Usage). Patient experienced the following unwanted or unexpected effects: factor viii inhibition. Recombinate dosage: . During the same period patient was treated with ADVATE (View Advate Review and Advate Label ). Patient was hospitalized.

5316020-9 | Factor Viii Inhibition
on May 01, 2007 Male patient from JAPAN , weighting 19.84 lb, was diagnosed with factor viii deficiency and was treated with Recombinate (View Usage). Patient had the following side effects: factor viii inhibition. Recombinate dosage: . During the same period patient was treated with ADVATE (View Advate Review and Advate Label ). Patient was hospitalized.

5278685-X | Hypotension, Loss Of Consciousness
Patient was taking Recombinate (View Usage). After Recombinate was administered, patient had the following side effects: hypotension, loss of consciousness on Mar 23, 2007 from JAPAN Additional patient health information: Male patient , child 7 years of age, was diagnosed with factor viii deficiency, haemarthrosis and. Recombinate dosage: .

5278684-8 | Hypotension, Loss Of Consciousness
Adverse event was reported on Mar 23, 2007 by a Male patient taking Recombinate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency, haemarthrosis and. Location: JAPAN , child 7 years of age, Patient experienced the following unwanted or unexpected effects: hypotension, loss of consciousness.

5245403-0 | Abdominal Haematoma, Cardiogenic Shock, Factor Viii Inhibition, Mechanical Ileus, Peritonitis, Pulmonary Embolism, Rectal Cancer, Renal Failure Acute, Sepsis
on Feb 09, 2007 Male patient from GERMANY , 69 years of age, weighting 165.3 lb, was diagnosed with haemophilia and was treated with Recombinate (View Usage). Patient had the following side effects: abdominal haematoma, cardiogenic shock, factor viii inhibition, mechanical ileus, peritonitis, pulmonary embolism (What is pulmonary embolism?), rectal cancer, renal failure acute, sepsis (What is sepsis?). Recombinate dosage: . Patient was hospitalized.

5238474-9 | Hypotension, Loss Of Consciousness
on Feb 08, 2007 Male patient from JAPAN , child 7 years of age, was diagnosed with factor viii deficiency, haemarthrosis and was treated with Recombinate (View Usage). After Recombinate was administered, patient had the following side effects: hypotension, loss of consciousness. Recombinate dosage: .

5238473-7 | Hypotension, Loss Of Consciousness
Patient was taking Recombinate (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, loss of consciousness on Feb 08, 2007 from JAPAN Additional patient health information: Male patient , child 7 years of age, was diagnosed with factor viii deficiency, haemarthrosis and. Recombinate dosage: .

5226755-4 | Hypotension, Loss Of Consciousness
Adverse event was reported on Jan 23, 2007 by a Male patient taking Recombinate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency, haemarthrosis and. Location: JAPAN , child 7 years of age, Patient had the following side effects: hypotension, loss of consciousness.

5219130-X | Anaphylactic Shock, Loss Of Consciousness
on Jan 15, 2007 Male patient from JAPAN , child 7 years of age, was diagnosed with factor viii deficiency and was treated with Recombinate (View Usage). After Recombinate was administered, patient had the following side effects: anaphylactic shock, loss of consciousness. Recombinate dosage: .

5202144-3 | Chest Pain, Throat Tightness
on Dec 07, 2006 Male patient from UNITED STATES , child 7 years of age, weighting 65.26 lb, was diagnosed with factor viii deficiency and was treated with Recombinate (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), throat tightness. Recombinate dosage: As Needed; Iv.

5136818-X | Activated Partial Thromboplastin Time Prolonged, Factor Viii Inhibition, Haemarthrosis
Patient was taking Recombinate (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, factor viii inhibition, haemarthrosis on Oct 02, 2006 from FRANCE Additional patient health information: Male patient , 13 years of age, was diagnosed with factor viii deficiency and. Recombinate dosage: See Image. During the same period patient was treated with HEXATRIONE (View Hexatrione Review and Hexatrione Label ). Patient was hospitalized.